Harold S. Luft
Amazon Price: $18.45
List Price: $27.95
Usually ships in 24 hours
By: Harvard University Press
Amazon Marketplace: 53
new & used starting at $10.85
|
Buy at Amazon.com
|
Browse similar items by category:
Subjects -> Business & Investing -> Industries & Professions -> Insurance -> Health
Subjects -> Business & Investing -> Industries & Professions -> Insurance -> General
Subjects -> Business & Investing -> Industries & Professions -> Insurance -> General AAS
Customer Reviews:
Total reviews: 1
Average rating: 5.0 of 5
Editorial Review:
Proposals to reform the health care system typically focus on either increasing private insurance or expanding government-sponsored plans. Guaranteeing that everyone is insured, however, does not create a system with the quality of care patients want, the flexibility clinicians need, and the internal dynamics to continually improve the value of health care.
In Total Cure, Hal Luft presents a comprehensive new proposal, SecureChoice, which does all that while providing affordable health insurance for every American. SecureChoice is a plan that restructures payment for medical care, harnessing the flexibility and responsiveness of the market by aligning the incentives of clinicians, hospitals, and insurers with those of the patient. It uses the accountability of government to ensure transparency, competition, and equity.
SecureChoice has two major components. A universal pool covers the major risks of hospitalization and chronic illness, which account for almost two-thirds of all costs. Everyone would be in the pool, irrespective of employment, income, or health status. The second component emphasizes choice, flexibility, and responsibility. People will be able to choose any physician to serve as their “medical home,” to keep track of their health records, provide much of their care, and suggest referrals. Clinicians will have the information and incentives to continually enhance quality. SecureChoice also facilitates improvements in areas ranging from malpractice to pharmaceuticals and establishes new roles for key stakeholders such as health insurers.
